5 citations
,
April 2025 in “Journal of the European Academy of Dermatology and Venereology” The EADV Task Force on Hair Diseases reviewed existing literature and clinical experience to propose diagnostic and therapeutic recommendations for managing folliculitis decalvans, highlighting oral antibiotics, glucocorticosteroids, isotretinoin, and various systemic and topical therapies as key options for managing inflammation and preventing further hair loss.
October 2025 in “Australasian Journal of Dermatology” In this systematic review of 728 patients, the researchers noted that combination therapies involving systemic antibiotics, topical, local, or other systemic agents may yield better outcomes and longer duration of effects for managing Folliculitis decalvans and Tufted Hair Folliculitis compared to systemic antibiotic monotherapy.
33 citations
,
January 2010 in “International journal of trichology” This case series reports 13 patients with folliculitis decalvans treated with antimicrobial therapy, highlighting the variability in response outcomes for this challenging condition.
37 citations
,
February 2015 in “Journal of the European Academy of Dermatology and Venereology” This study found that among patients with folliculitis decalvans, treatment with isotretinoin achieved the highest rate of stable remission compared to antibiotic regimens like clindamycin and rifampicin.
March 2023 in “JAAD case reports” In this study, researchers reported that conventional treatments for folliculitis decalvans, which include steroids and antibiotics, are often ineffective, with many patients experiencing frequent recurrences of this scarring scalp disorder.
